DV
Dividend Vision

ERNA — Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc. (ERNA)

Its deepest 1-year drawdown was 93.0%.

# Summary Based on the data provided, this equity fund tracks a single stock rather than functioning as a traditional diversified ETF. With no distribution rate, expense ratio, or asset under management data available, this appears to be either a closed or inactive fund structure. The lack of key ETF metrics and specified objective makes it unsuitable for typical income-focused dividend investors seeking regular distributions and transparent fee structures.

ERNA key facts

Asset type
Stock
Asset class
Equity
Inception date
08/29/1991
Distribution frequency
None
Last close
$4.27
Market cap
$4,980,242
Average volume
26009.0
Beta
2.562
Payout ratio
0.0
P/E ratio
0.005
Forward P/E
0.0
EPS
$-0.41